We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AM:EURONEXT PARISDassault Aviation SA Analysis

Data as of 2026-06-03 - not real-time

$21.27

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Antero Midstream trades around $21.27, which sits above the DCF‑derived fair value of roughly $10.5, indicating a material overvaluation despite a modest upside estimate of about 9½ %. The company posted a solid revenue beat (+4.7 % vs. consensus) and a modest EPS miss, while free cash flow before dividends rose 8 % YoY to $192 million, yet the payout ratio exceeds 100 %, raising concerns about dividend sustainability. Operating margins remain robust (over 55 %) and EBITDA growth is expected in the high‑single‑digit range, supported by a recent $1.1 billion acquisition that should enhance cash flow generation. However, leverage is extreme, with a debt‑to‑equity ratio north of 190, and the balance sheet is heavily weighted toward debt, which could limit financial flexibility. Technical indicators show a neutral price trend, a bearish MACD crossover, decreasing volume, and RSI near the midpoint, suggesting limited near‑term upside and potential downside toward the $20.67 support level.
Conclusion: While the business fundamentals and cash‑flow profile are solid, the combination of overvaluation, high leverage, and an unsustainable dividend payout tilts the risk‑reward balance toward caution. Investors should monitor debt‑service metrics and any forward‑looking guidance on dividend policy, as these will be decisive for longer‑term positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume signal limited upside
  • Price near technical support at $20.67
  • Revenue beat offsets EPS miss

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio constrains financial flexibility
  • Strong operating margins and cash‑flow generation
  • Dividend payout above 100 % of earnings raises sustainability concerns

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation relative to DCF fair value
  • Elevated leverage and potential refinancing risk
  • Unsustainable dividend policy could lead to cutbacks

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin31.94%
P/E Ratio24.7
ROE20.41%
ROA7.61%
Debt/Equity191.72
P/B Ratio5.2
Op. Cash Flow$972.1M
Free Cash Flow$457.1M
Industry P/E21.3

Technical Analysis

TrendNeutral
RSI45.3
Support$20.67
Resistance$22.55
MA 20$21.53
MA 50$21.85
MA 200$19.67
MACDBearish
VolumeDecreasing
Fear & Greed Index92.75

Valuation

Fair Value$10.51
Target Price$23.29
Upside/Downside9.48%
GradeOvervalued
TypeBlend
Dividend Yield4.24%

Risk Assessment

Beta0.01
Volatility21.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.